Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma ; volume:6 ; number:6 ; day:22 ; month:9 ; year:2004 ; pages:1-7 ; date:12.2004
Breast cancer research ; 6, Heft 6 (22.9.2004), 1-7, 12.2004
- Urheber
-
Kitayama, Joji
- Beteiligte Personen und Organisationen
-
Shida, Dai
Sako, Akihiro
Ishikawa, Makoto
Hama, Kotaro
Aoki, Junken
Arai, Hiroyuki
Nagawa, Hirokazu
SpringerLink (Online service)
- DOI
-
10.1186/bcr935
- URN
-
urn:nbn:de:1111-2016032354697
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kitayama, Joji
- Shida, Dai
- Sako, Akihiro
- Ishikawa, Makoto
- Hama, Kotaro
- Aoki, Junken
- Arai, Hiroyuki
- Nagawa, Hirokazu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast
Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma
The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast
Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
Common genetic susceptibility to DCIS and invasive ductal carcinoma
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast
The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma
Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast
Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma
The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast
Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
Common genetic susceptibility to DCIS and invasive ductal carcinoma
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast
The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma
Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast
Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma
The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast
Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
Common genetic susceptibility to DCIS and invasive ductal carcinoma
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast